News | Imaging Software Development | August 29, 2025

HeartFocus Introduces First U.S. Clinical Product on Butterfly Network

FDA-cleared AI-guided cardiac imaging software now available for all U.S healthcare professionals.

HeartFocus Introduces First U.S. Clinical Product on Butterfly Network

Aug. 27, 2025 – HeartFocus, the AI-enabled cardiac imaging software developed by data-driven medtech company DESKi, announced its U.S. commercial launch. HeartFocus will initially be available on Butterfly Network’s handheld ultrasound devices, the FDA-cleared software enables any healthcare professional to conduct diagnostic-quality heart ultrasounds after just hours of training. Health systems, primary care clinics, and clinical education institutions can now access the application. 

Following recent FDA clearance and a successful international clinical trial, HeartFocus has moved from pilot to full deployment, empowering healthcare professionals to conduct fast and comprehensive cardiac assessments anywhere patients are seen, from rural clinics to primary care, education, cardiology, and even in acute high-volume triage environments.

HeartFocus addresses the most persistent barriers in cardiac care: limited access to trained sonographers and long wait times for diagnostic imaging. With just hours of training, any healthcare professional using HeartFocus can capture comprehensive echocardiographic views with consistency that has been clinically proven to match expert operators. Now commercially available through Butterfly Network’s single-probe, whole-body ultrasound system, providing seamless AI integration.

Bertrand Moal, PhD, MD, CEO of DESKi said, “With HeartFocus, we’re unlocking access to life-saving heart scans wherever they’re needed most. This isn’t just a product launch, it represents phase one in our mission to transform how and where cardiac care is delivered, setting a new standard in accessibility and impact.”

Davinder Ramsingh, VP, Innovation Partnerships and Clinical Development at Butterfly Network, said, “This commercial launch marks a first within the Butterfly Garden, offering deep integration with one of the most widely adopted handheld ultrasound systems in the U.S. We’re thrilled to bring HeartFocus to healthcare professionals nationwide. By combining Butterfly’s handheld device with HeartFocus’ AI-powered software, we’re enabling earlier detection and better outcomes, from large health systems to rural, underserved communities.”

Now addressing increasing cardiac care needs, HeartFocus empowers providers of all levels to deliver timely, high-quality cardiac care, anywhere it’s needed.

To learn more, visit www.heartfocus.ai 


Related Content

News | FDA

July 28, 2026 — Implicity has been granted U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its next ...

Home July 30, 2026
Home
News | FDA

July 24, 2026 — MannKind Corp. recently announced that the U.S. Food and Drug Administration (FDA) has approved Furoscix ...

Home July 28, 2026
Home
News | FDA

July 21, 2026 — ElectroWire Medical recently announced that the U.S. Food and Drug Administration (FDA) has granted 510 ...

Home July 23, 2026
Home
News | FDA

July 14, 2026 — Atrium Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has cleared its ...

Home July 14, 2026
Home
News | FDA

July 7, 2026 — W. L. Gore & Associates’ medical business recently announced that the U.S. Food and Drug Administration ...

Home July 13, 2026
Home
News | FDA

June 15, 2006 — Penumbra, Inc. has secured the CE Mark in Europe for Thunderbolt, further laying the groundwork for ...

Home June 15, 2026
Home
News | FDA

June 9, 2026.— Pentixapharm Holding AG has announced that the U.S. Food and Drug Administration (FDA) has cleared its ...

Home June 09, 2026
Home
News | FDA

April 16, 2026 — The U.S. Food and Drug Administration has granted 510(k) clearance to Royal Philips for its Philips ...

Home April 20, 2026
Home
News | FDA

April 7, 2026 —TRiCares SAS has received approval from the U.S. Food and Drug Administration (FDA) for an ...

Home April 09, 2026
Home
News | FDA

April 8, 2026 — Anumana, Inc. recently announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI ...

Home April 08, 2026
Home
Subscribe Now